Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia)
A phase 3 trial of Glasdegib in Acute myeloid leukaemia, run by University Hospital Heidelberg, recorded as terminated on the registry.
Overview
Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia) is a phase 3 interventional study registered as NCT04093505 by University Hospital Heidelberg, with 28 participants recorded, started 2021-04-01 and due to reach its primary completion in 2022-06-15. Interventions recorded: Gemtuzumab Ozogamicin 147, Gemtuzumab Ozogamicin 1, Glasdegib, Placebo Oral Tablet. Conditions recorded: Acute Myeloid Leukemia.
Linked to the drug Glasdegib because the registry names it among its interventions and Acute myeloid leukaemia among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialContinuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML
Shares Glasdegib, Acute myeloid leukaemia and the tag pipeline.
- TrialMocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Shares Acute myeloid leukaemia and the tag pipeline.
- TrialPhase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Shares Acute myeloid leukaemia and the tag pipeline.
- TrialAn Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission
Shares Acute myeloid leukaemia and the tag pipeline.
- TrialA Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia
Shares Glasdegib and the tag pipeline.
- TrialA Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Shares Acute myeloid leukaemia and the tag pipeline.
- TrialStudy Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy
Shares Acute myeloid leukaemia and the tag pipeline.
- TrialA Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Shares Acute myeloid leukaemia and the tag pipeline.